Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
News|Slideshows|September 2, 2015
Migraine: Keeping the Beast at Bay
Author(s)Leo Robert
Do you know what drugs current guidelines recommend? Get an 8-slide update, here.
Advertisement
About 38% of migraineurs need preventive therapy, but only about 3% to 13% currently use it, according to the American Academy of Neurology (AAN). Since the AAN published guidelines for migraine prevention in 2000, new clinical studies have addressed and readdressed the efficacy and safety of migraine preventive therapies.The short slide show above reviews guideline-endorsed pharmacotherapy for migraine prevention, behavioral interventions, and new research on difficult comorbid conditions.Â
Advertisement
Related to this article
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
Plasma p-tau217 levels helped estimate 5- and 10-year cognitive impairment risk in older adults without memory or thinking symptoms.
FDA cleared C2N’s PrecivityAD2 blood test to aid Alzheimer disease evaluation in symptomatic adults aged 40 years and older.
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
3
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
4
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
5